Acta Epileptologica

Scope & Guideline

Transforming epilepsy research through open access.

Introduction

Immerse yourself in the scholarly insights of Acta Epileptologica with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN2096-9384
PublisherSPRINGERNATURE
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 2019 to 2024
AbbreviationACTA EPILEPTOL / Acta Epileptol.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

Acta Epileptologica is a journal dedicated to advancing the understanding of epilepsy through the exploration of its mechanisms, treatment approaches, and patient management strategies. The journal encompasses a wide range of research topics that reflect the multifaceted nature of epilepsy as a neurological disorder.
  1. Mechanisms of Epilepsy:
    Research focused on understanding the biological, genetic, and molecular mechanisms underlying various forms of epilepsy, including biomolecular pathways, genetic mutations, and neurophysiological changes.
  2. Clinical Management and Treatment:
    Studies investigating the efficacy and safety of different therapeutic interventions, including pharmacological treatments, dietary therapies, and surgical options for managing epilepsy.
  3. Patient-Centric Research:
    Research emphasizing the quality of life, psychological impact, and social aspects of living with epilepsy, including stigma, comorbidities, and health-related quality of life.
  4. Diagnostic Innovations:
    Exploration of new diagnostic techniques and biomarkers for epilepsy, including advanced imaging methods and electrophysiological assessments.
  5. Epidemiology and Risk Factors:
    Studies examining the prevalence, risk factors, and demographic aspects of epilepsy across different populations, with a focus on understanding variations in incidence and access to care.
Acta Epileptologica has seen a rise in research themes that reflect current advancements in the field, addressing contemporary challenges and innovations in epilepsy management.
  1. Personalized Medicine and Genetic Research:
    An increasing emphasis on personalized treatment strategies based on genetic profiles and biomarkers, which is crucial for tailoring interventions for drug-resistant epilepsy.
  2. Neurotechnology and Neuromodulation:
    Growing interest in the application of neurotechnological advancements, including neuromodulation techniques such as vagus nerve stimulation and deep brain stimulation, for managing epilepsy.
  3. Dietary and Lifestyle Interventions:
    A notable trend towards exploring dietary therapies, particularly ketogenic diets, as alternative treatment options, reflecting a shift towards holistic management approaches.
  4. Impact of Comorbidities on Epilepsy:
    Research focusing on the psychological and social comorbidities associated with epilepsy, highlighting the importance of comprehensive care that addresses both neurological and psychosocial aspects.
  5. Advanced Imaging and Biomarkers:
    Emerging studies utilizing advanced imaging techniques and identifying biomarkers to better understand epilepsy mechanisms, improve diagnostics, and predict treatment outcomes.

Declining or Waning

Over recent years, certain research themes within Acta Epileptologica have shown a decline in prominence, indicating a possible shift in focus or a saturation of interest in these areas.
  1. Traditional Pharmacological Approaches:
    While pharmacological treatments remain a core focus, there is a noticeable decline in studies centered solely on traditional antiepileptic drugs, possibly due to the emergence of novel therapies and personalized medicine approaches.
  2. Generalized Epilepsies:
    Research specifically targeting generalized epilepsies appears to be waning, with more attention shifting towards focal epilepsy and drug-resistant cases, reflecting evolving clinical priorities.
  3. Non-epileptic Seizures:
    The focus on psychogenic non-epileptic seizures (PNES) is less prevalent, suggesting a potential decrease in interest or a shift towards integrating these studies within broader epilepsy research.

Similar Journals

International Journal of Chronic Obstructive Pulmonary Disease

Advancing Knowledge in COPD Management
Publisher: DOVE MEDICAL PRESS LTDISSN: 1178-2005Frequency: 1 issue/year

The International Journal of Chronic Obstructive Pulmonary Disease, published by DOVE MEDICAL PRESS LTD, serves as a premier platform for researchers and professionals involved in the study and management of COPD. Established in 2006 and transitioning to an Open Access model in 2009, this journal has quickly gained a reputable standing in various impactful categories, achieving Q1 rankings in Health Policy, Medicine (Miscellaneous), and Public Health, among others. With a focus on disseminating high-quality research, the journal is pivotal for addressing global public health challenges associated with chronic obstructive pulmonary disease. The journal's dedication to open access ensures that vital information reaches a broader audience, fostering advancements in research and clinical practice. By maintaining rigorous peer-review standards and a commitment to the advancement of understanding in COPD, the journal attracts significant contributions from scientists and practitioners worldwide, making it an invaluable resource for ongoing education and research development in this critical area.

Neurology and Therapy

Unlocking Insights into Neurological Disorders and Treatments
Publisher: SPRINGER LONDON LTDISSN: 2193-8253Frequency: 2 issues/year

Neurology and Therapy, published by SPRINGER LONDON LTD, stands as a pivotal platform for researchers and practitioners in the field of neurology and its therapeutic applications. This Open Access journal, active since 2012, facilitates the dissemination of innovative studies and cutting-edge findings aimed at improving neurological health. With an impressive ranking in the 2023 Scopus Rankings, where it holds a Q2 category in Neurology and a Q1 category in Clinical Neurology, it underscores its prominence in advancing neurological research. The journal's intriguing scope encompasses a wide-ranging exploration of neurological disorders, treatment methodologies, and healthcare strategies, making it a valuable resource for those vested in enhancing patient outcomes. With an appealing average impact factor, readers are encouraged to dive into the latest advancements and engage with the scholarly discussions that are shaping the future of neurology.

EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY

Enhancing child health outcomes with rigorous scholarship.
Publisher: ELSEVIER SCI LTDISSN: 1090-3798Frequency: 6 issues/year

European Journal of Paediatric Neurology, published by Elsevier Science Ltd, is a premier academic journal dedicated to advancing the field of paediatric neurology. With its ISSN 1090-3798 and E-ISSN 1532-2130, this journal serves as a vital resource for researchers, clinicians, and students alike, focusing on the latest findings and innovative treatments in paediatric neurological disorders. The journal has established itself as a leading publication in its field, achieving a Q1 classification in Pediatrics, Perinatology and Child Health, and holding a reputable Q2 status in Clinical Neurology as of 2023. Positioned within the top 88th percentile in Pediatrics and the 76th percentile in Clinical Neurology according to Scopus ranks, it publishes rigorous peer-reviewed articles that contribute significantly to clinical practice and research. Although not open access, the journal provides vital insights into the complexities of neurological conditions affecting the pediatric population, making it an essential tool for scholars and professionals striving to improve child health outcomes. With a publication trajectory spanning from 1997 to 2024, it continues to be at the forefront of paediatric neurological research, inspiring innovation and collaboration in the scientific community.

Current Journal of Neurology

Advancing neurology through open dialogue.
Publisher: TEHRAN UNIV MEDICAL SCIENCESISSN: 2717-011XFrequency: 4 issues/year

Current Journal of Neurology, published by Tehran University of Medical Sciences, is an esteemed Open Access journal dedicated to advancing the field of neurology. Since its inception in 2011, the journal has provided a platform for innovative research and critical discourse in neurology and clinical neurology, with a focus on the latest advancements and methodologies. Although the journal currently holds a Q4 quartile ranking in both neurology and clinical neurology, its goal is to foster the global dissemination of knowledge and ideas relevant to the complexities of neurological disorders. Researchers, professionals, and students exploring this dynamic field will find valuable insights, as the journal aims to bridge the gap between emerging research and clinical application. Based in Tehran, Iran, the Current Journal of Neurology welcomes contributions that enhance understanding and treatment of neurological conditions, thereby promoting evidence-based practices across the globe.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

Pioneering knowledge in neurology and seizures.
Publisher: W B SAUNDERS CO LTDISSN: 1059-1311Frequency: 10 issues/year

SEIZURE - EUROPEAN JOURNAL OF EPILEPSY is a leading journal published by W B SAUNDERS CO LTD, specializing in the field of epilepsy and seizure disorders. Since its inception in 1992, this journal has committed itself to advancing research and understanding in neurology, achieving a respectable 2023 impact factor reflected by its Q2 rankings in Medicine (miscellaneous), Neurology, and Clinical Neurology categories. With an impressive Scopus ranking that places it in the top 35% of journals in Neuroscience and Neurology, SEIZURE is dedicated to promoting high-quality research and clinical studies that offer insights into epilepsy management and treatment. Although not an open-access journal, it maintains a diverse array of original articles, reviews, and case studies catering to academicians, medical professionals, and students looking to expand their knowledge on epilepsy. This journal is pivotal for those seeking to stay abreast of the latest trends, therapies, and findings in the neuroclinical landscape.

Epilepsy & Behavior Reports

Fostering Collaboration for a Deeper Understanding of Epilepsy
Publisher: ELSEVIER SCIENCE INCISSN: Frequency: 1 issue/year

Epilepsy & Behavior Reports, a distinguished journal published by ELSEVIER SCIENCE INC, specializes in the latest research and developments in the field of epilepsy and related behavioral conditions. Since its inception in 2019 as a fully Open Access journal, it has carved a niche for itself within the scientific community, providing an essential platform for researchers and clinicians focused on behavioral neuroscience and neurology. The journal's commitment to disseminating high-quality research is reflected in its current rankings within Scopus, placing it within the Q3 category for Behavioral Neuroscience and Clinical Neurology, underscoring its relevance to emerging trends in these fields. Located in the heart of New York, the journal strives to foster collaboration and innovation, making it a vital resource for academics, practitioners, and students eager to advance their understanding of epilepsy and its behavioral implications. The convergence of expertise and research in Epilepsy & Behavior Reports promises to illuminate crucial aspects of neurological health, driving forward the discourse that shapes future treatment and understanding of epilepsy.

Neurology Research International

Connecting Researchers for a Brighter Neurological Future
Publisher: HINDAWI LTDISSN: 2090-1852Frequency:

Neurology Research International, published by HINDAWI LTD, is an esteemed open access journal that has been serving the neurology community since 2010. With its ISSN 2090-1852 and E-ISSN 2090-1860, this journal aims to foster knowledge dissemination and facilitate dialogue surrounding key issues in neurology and clinical neuroscience, making it a vital resource for researchers, clinicians, and students alike. It operates from the United States, with its administrative hub located in London, England. As of 2023, the journal has been positioned in the Q3 category for both neurology and clinical neurology, reflecting its commitment to advancing research within these critical fields. With a current Scopus rank of #216/400 in clinical neurology and a #113/192 in neuroscience, and a converged publication timeline from 2010 to 2024, Neurology Research International is dedicated to promoting high-quality research that addresses contemporary challenges and innovations in neurological science. By offering open access since its inception, it ensures that cutting-edge research is freely available, aligning with the global push towards accessible scientific communication.

JAMA Neurology

Shaping the Future of Neurology One Article at a Time
Publisher: AMER MEDICAL ASSOCISSN: 2168-6149Frequency: 12 issues/year

JAMA Neurology is a leading peer-reviewed journal published by the American Medical Association, focused on advancing the understanding and treatment of neurological disorders. With an impressive impact factor and ranked in the 99th percentile among clinical neurology journals, this publication is recognized as Q1 in its category for 2023, highlighting its significance in the field. Since its inception, the journal has provided a platform for high-quality research, clinical trials, and reviews that inform both clinicians and researchers. Operating from its headquarters in Chicago, Illinois, JAMA Neurology offers rich insights into the latest advancements in neurology, featuring articles that span a wide range of topics including neurodegenerative diseases, stroke, epilepsy, and neurocritical care. Researchers and professionals are encouraged to access the journal’s content freely, as it employs open access options to promote the dissemination of critical knowledge. As a critical resource in the field of neurology, JAMA Neurology is essential for anyone involved in this dynamic and rapidly evolving specialty.

REVUE NEUROLOGIQUE

Driving Innovation in Neurological Disorders and Treatments
Publisher: MASSON EDITEURISSN: 0035-3787Frequency: 10 issues/year

REVUE NEUROLOGIQUE, published by MASSON EDITEUR, is a prestigious academic journal that plays an essential role in the field of neurology. With a rich history spanning from 1946 to the present, this journal focuses on both foundational and clinical aspects of neurology, underscoring its significance within the medical community. Holding an impressive Q2 ranking in both general and clinical neurology categories as of 2023, REVUE NEUROLOGIQUE is recognized for its contribution to advancing neurological science, as evidenced by its Scopus rankings, with a notable position in the 62nd percentile for clinical neurology. The journal fosters an environment for rigorous research and is instrumental for professionals and scholars aiming to stay abreast of the latest developments in neurological disorders and treatments. Although it is not an open-access publication, it offers a wealth of vital research through its issues, appealing to those engaged in both clinical practice and academic research in neurology.

Epilepsi

Fostering breakthroughs in epilepsy management and care.
Publisher: KARE PUBLISSN: 1300-7157Frequency: 3 issues/year

Epilepsi is an esteemed academic journal dedicated to advancing the field of epilepsy research and treatment, published by KARE PUBL. With its open access model established since 2017, the journal ensures that vital research findings are easily accessible to a global audience, thereby fostering collaboration and knowledge sharing among researchers, healthcare professionals, and students. The journal focuses on a comprehensive range of topics within neurology, including clinical studies, therapeutic advancements, and innovative approaches to epilepsy management. Located in Istanbul, Turkey, Epilepsi aims to bridge the gap between research and practice, enhancing understanding and patient care for individuals affected by epilepsy. Its commitment to high-quality, peer-reviewed content makes it a significant resource for anyone involved in epilepsy research or clinical practice.